You are here


New Report Shows Devastating Effect of COVID-19 Pandemic on TB Response: 6.3 Million More People Ill with TB and 1.4 Million More TB Deaths by 2025
Length of quarantine, movement restrictions and disruption of TB services could spell disaster for hundreds of thousands at risk
South Africa begins Covid-19 BCG vaccine trial
TASK, a medical trials centre in Cape Town, has administered a Bacille Calmette-Guérin (BCG) vaccine to 250 healthcare workers as part of a clinical study to help fight off the effects of Covid-19.
COVID-19: Don’t take BCG vaccine away from kids who need it for TB, experts say
A recent report claiming that the anti-tuberculosis (TB) vaccine, known as the BCG vaccine, protects against COVID-19 should be “interpreted with extreme caution”, according to a group of leading TB experts writing in the International Journal of Tuberculosis and Lung Disease. Authors of the new paper published on Tuesday include leading South African researchers Dr Mark Cotton, Professor Simon Schaaf and Dr Anneke Hesseling.
Union warns the COVID-19 pandemic must not divert attention from the needs of children and adolescents in TB-endemic African countries
The Union warned that if resources are diverted away from child and adolescent tuberculosis (TB) programmes in order to fight COVID-19, the consequences for the estimated 400,000 children and adolescents in the African region needing TB and multidrug-resistant TB care each year could be devastating.
The TB Response is Heavily Impacted by the COVID-19 Pandemic
08 April 2020, Geneva, Switzerland - Stop TB Partnership Secretariat organized a rapid assessment of the impact the  COVID19 pandemic and related measures have on the TB response in 20 High Burden Countries that represent 54% of the global TB burden, through interviews with National TB Programmes (NTPs) and focal points based on a set of open-ended questions. Similarly, the Global Coalition of TB Activists (GCTA) did a worldwide survey through their network of members collecting answers from TB civil society and communities from 16 countries, with data updated regularly.
Tuberculosis and HIV responses threatened by COVID-19
March 24, 2020, was World Tuberculosis Day 2020, but this year tuberculosis was overshadowed by the COVID-19 pandemic. By the end of that week, COVID-19 had already exceeded 600 000 confirmed cases and about 30 000 deaths worldwide. Before the emergence of COVID-19 as a public health emergency of international concern, coinfection with tuberculosis was probably the priority for HIV/AIDS control efforts in Africa.
Survivors and activists demand increased action against TB
While the almost 70% price reduction in important tuberculosis prevention drug Rifapentine for 100 countries with significant TB epidemics is a breakthrough, the high cost of newer drugs remains a barrier.
Union response to the WHO 2019 Global Tuberculosis Report
The latest Global Tuberculosis Report has been launched by the World Health Organization (WHO). Dr Paula I Fujiwara, Scientific Director of The Union responds.  "It is extremely concerning that the WHO's 2019 Global TB Report confirms that tuberculosis (TB) remains the single most lethal infectious disease globally, surpassing HIV/AIDS, killing some 1.6 million people annually, and that the end of TB will remain out of reach until national leaders step up," said Dr Fujiwara.